New developments in adverse drug reaction of ART and tertiary car | 55814
Journal of Clinical Trials

Journal of Clinical Trials
Open Access

ISSN: 2167-0870

+44 7868 792050

New developments in adverse drug reaction of ART and tertiary care

8th Global Pharmacovigilance & Drug Safety Summit


Rahul Hajare

Indian Council of Medical Research, India

Scientific Tracks Abstracts: J Clin Trial

Abstract :

The present study reported that clinical pharmacist play a key role in patient safety. Particularly in ART department, they are important for educating guiding the health care professionals related to safety use of medications. Even though drug related problems were found, after reporting information to physicians, we are minimizing harm to patients. In future, clinical pharmacy services are one of the effective services in hospital to improve the quality of life of patients in hospitals. By implementing such practices in the hospitals and country, we can make the country and society free of diseases. These findings raise the issue related to control of HIV multiplication. It is hoped that with the introduction of a new role, the situation for patient living with HIV/AIDS in the hospitals in India will continue to improve. This includes less relocation of PLHA; hence the claim by outstanding importance of inpatient cares in HIV infection in people. This also shows the outstanding importance of inpatient care in PLHA and provided indications that the patient's life could lead to less relocation, because relocation basically means risks and stress for all concerned.

Biography :

Rahul Hajare has completed his PhD from Vinayaka Missions University. He is a former Post-Doctoral Fellow of (7th Batch) Indian Council of Medical Research New Delhi in 2013, where he achieved Post-doc Degree under the guidance and supervision of Eminent Scientist Dr. Ramesh Paranjape, retired as Director and Scientist ‘G’ National AIDS Research Institute, India. He has published more than 47 papers in reputed journals and has been serving as an Editorial Board Member of repute.